Jonathan Block
Stock Analyst at Stifel Nicolaus
(4.10)
# 1,613
Out of 4,534 analysts
609
Total ratings
51%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintained: Buy | $675 | $563.81 | +19.72% | 67 | Jul 15, 2026 | |
| PODD Insulet | Rated: Buy | $250 → $225 | $167.37 | +34.43% | 6 | Jul 10, 2026 | |
| NYXH Nyxoah | Reiterated: Hold | $3 | $1.56 | +92.31% | 37 | Jul 9, 2026 | |
| RMD ResMed | Reiterated: Hold | $235 | $198.61 | +18.32% | 11 | Jul 8, 2026 | |
| ZTS Zoetis | Rated: Hold | $95 → $85 | $76.20 | +11.55% | 57 | Jun 26, 2026 | |
| TRUP Trupanion | Reiterated: Hold | $28 | $26.74 | +4.71% | 43 | Jun 26, 2026 | |
| COO The Cooper Companies | Maintained: Buy | $85 | $71.59 | +18.73% | 36 | Jun 12, 2026 | |
| DXCM DexCom | Rated: Buy | $85 → $90 | $75.69 | +18.91% | 6 | Jun 5, 2026 | |
| ALGN Align Technology | Maintained: Buy | $210 | $175.05 | +19.97% | 103 | May 25, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $25.14 | - | 40 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $5.11 | +56.56% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $26.58 | +16.63% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $13.46 | +4.01% | 43 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $84 | $86.20 | -2.55% | 33 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $65 | $53.27 | +22.02% | 40 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $20 | $17.82 | +12.23% | 6 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.7883 | +153.71% | 17 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $22 | $18.10 | +21.55% | 4 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $0.9256 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $45 | $155.46 | n/a | 22 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 | $0.0002 | n/a | 1 | Jul 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $41 → $47 | $272.67 | n/a | 3 | May 15, 2017 |
IDEXX Laboratories
Jul 15, 2026
Maintained: Buy
Price Target: $675
Current: $563.81
Upside: +19.72%
Insulet
Jul 10, 2026
Rated: Buy
Price Target: $250 → $225
Current: $167.37
Upside: +34.43%
Nyxoah
Jul 9, 2026
Reiterated: Hold
Price Target: $3
Current: $1.56
Upside: +92.31%
ResMed
Jul 8, 2026
Reiterated: Hold
Price Target: $235
Current: $198.61
Upside: +18.32%
Zoetis
Jun 26, 2026
Rated: Hold
Price Target: $95 → $85
Current: $76.20
Upside: +11.55%
Trupanion
Jun 26, 2026
Reiterated: Hold
Price Target: $28
Current: $26.74
Upside: +4.71%
The Cooper Companies
Jun 12, 2026
Maintained: Buy
Price Target: $85
Current: $71.59
Upside: +18.73%
DexCom
Jun 5, 2026
Rated: Buy
Price Target: $85 → $90
Current: $75.69
Upside: +18.91%
Align Technology
May 25, 2026
Maintained: Buy
Price Target: $210
Current: $175.05
Upside: +19.97%
Elanco Animal Health
May 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.14
Upside: -
May 11, 2026
Maintained: Hold
Price Target: $9 → $8
Current: $5.11
Upside: +56.56%
May 7, 2026
Maintained: Buy
Price Target: $31
Current: $26.58
Upside: +16.63%
May 6, 2026
Reiterated: Hold
Price Target: $14
Current: $13.46
Upside: +4.01%
May 6, 2026
Reiterated: Hold
Price Target: $84
Current: $86.20
Upside: -2.55%
May 5, 2026
Maintained: Buy
Price Target: $70 → $65
Current: $53.27
Upside: +22.02%
Apr 22, 2026
Maintained: Buy
Price Target: $22 → $20
Current: $17.82
Upside: +12.23%
Mar 13, 2026
Reiterated: Hold
Price Target: $2
Current: $0.7883
Upside: +153.71%
Feb 20, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $18.10
Upside: +21.55%
Jan 7, 2022
Maintained: Buy
Price Target: $10 → $9
Current: $0.9256
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $55 → $45
Current: $155.46
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $41 → $47
Current: $272.67
Upside: n/a